
Article 1 
Lipid extract from Antarctic Krill (Euphausia superba) as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses defined and at the maximum levels established in Annex II without prejudice to the specific provisions of Directive 2002/46/EC.
Article 2 
The designation of a lipid extract from Antarctic Krill (Euphausia superba) authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘lipid extract from the crustacean Antarctic Krill (Euphausia superba)’.
Article 3 
This Decision is addressed to Aker BioMarine Antarctic AS, PO Box 496, NO-1327 Lysaker, Norway.
Done at Brussels, 14 April 2016.
For the Commission
Vytenis ANDRIUKAITIS
Member of the Commission
ANNEX I

Description: To produce lipid extract from Antarctic Krill (Euphausia superba), milled Antarctic Krill is subjected to an extraction with ethanol. Proteins and krill material are removed from the lipid extract by filtration. The ethanol and residual water are removed by evaporation.

Test Specification
Saponification value Not more than 185 mg KOH/g
Peroxide value (PV) Not more than 2 meq O2/kg oil
Moisture and volatiles Not more than 0,6
Phospholipids Not less than 35 % w/w
Trans-fatty acids Not more than 1 % w/w
EPA (eicosapentaenoic acid) Not less than 15 % of total fatty acids
DHA (docosahexaenoic acid) Not less than 7 % of total fatty acids

ANNEX II

Food category Maximum content of combined DHA and EPA
Food supplements as defined in Directive 2002/46/EC. 3 g per day for general population450 mg per day for pregnant and lactating women
Note: All food products containing DHA- and EPA-rich oil from Antarctic Krill should demonstrate oxidative stability by appropriate and recognised national/international test methodology (e.g. AOAC).